Clinical Management of Risk of Radiation Pneumonia with Serum Markers During the Radiotherapy for Patients with Thoracic Malignant Tumors

PURPOSE: Risk of radiation pneumonia (RP) could not be effectively detected due to non-specific clinical symptoms in the early stage. The purpose of this investigation was to evaluate serum biomarkers of cytokines interleukin-6 (IL-6), C-reactive protein (CRP) and procalcitonin (PCT) for its early d...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yuxia, Qiu, Ting, Patel, Nishant, Zhou, Shi, Xue, Tao, Zhang, Haijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901038/
https://www.ncbi.nlm.nih.gov/pubmed/31824195
http://dx.doi.org/10.2147/CMAR.S231995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901038/
https://www.ncbi.nlm.nih.gov/pubmed/31824195
http://dx.doi.org/10.2147/CMAR.S231995

Ejemplares similares